[Newsdesk] MSF challenges pneumococcal vaccine patent in India

Pfizer and GSK dominate pneumococcal vaccine manufacturing, but an impending court case in India could pave the way for others, which MSF hopes will drive down costs. Ann Danaiya Usher reports.

Source: The Lancet Infectious Diseases - February 7, 2018 Category: Infectious Diseases Authors: Ann Danaiya Usher Tags: Newsdesk Source Type: research